Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase EARLY_PHASE1 1Phase 1/2 1Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 182Triple Negative Breast Neoplasms 24Lung Neoplasms 16Ovarian Neoplasms 11Melanoma 11Prostatic Neoplasms 10Pancreatic Neoplasms 10Colonic Neoplasms 10Sarcoma 9Neoplasms 8Stomach Neoplasms 7Carcinoma, Intraductal, Noninfiltrating 7Head and Neck Neoplasms 6Colorectal Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Urinary Bladder Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Carcinoma, Renal Cell 5Breast Neoplasms, Male 5Uterine Cervical Neoplasms 4Glioblastoma 4Carcinoma, Ductal, Breast 4Brain Neoplasms 4Small Cell Lung Carcinoma 3Liver Neoplasms 3Kidney Neoplasms 3Endometrial Neoplasms 3Carcinoma, Lobular 3Carcinoma, Hepatocellular 3Rectal Neoplasms 2

Interventions

proto-oncogene protein c-fes-fps 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Estrogen Receptor Positive Breast Cancer × Breast × Clear all
NCT04727632 2024-10-28

[18F]Fluoroestradiol-PET/CT Companion Imaging Study to the FORESEE Trial

University of Utah

Phase EARLY_PHASE1 Terminated
2 enrolled
Breast

Estrogen Receptor Positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡